Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.5200
+0.0300 (6.12%)
Nov 24, 2025, 4:00 PM EST - Market closed
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $45.4 million as of November 25, 2025. Its market cap has decreased by -63.43% in one year.
Market Cap
45.40M
Enterprise Value
-42.39M
1-Year Change
-63.43%
Ranking
Category
Stock Price
$0.52
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $45.40M, a decrease of -95.68%. That is a compound annual growth rate of -50.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 45.40M | -47.14% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
| Jun 18, 2021 | 1.05B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |